San Juan LGU starts COVID-19 vaccination of children aged 12-17

Published October 22, 2021, 10:25 AM

by Patrick Garcia

The San Juan City local government started on Friday, Oct. 22, the inoculation of children aged 12 to 17 after the Inter-Agency Task Force (IATF) approved the vaccination of minors against COVID-19.

(Screenshot from PTV-4 Facebook Live)

San Juan City Mayor Francis Zamora, together with National Task Force Consultant Dr. Ted Herbosa, Department of Health Undersecretary Dr. Roger P. Tong-An, and Department of Interior and Local Government Undersecretary Jonathan Malaya led the vaccination of 140 minors with comorbidities at the Cardinal Santos Medical Center.

Zamora said the vaccination of minors is in time for the proposed resumption of face-to-face classes which was halted due to the pandemic.

He added that the launch was immediately scheduled after the IATF released the guidelines for the vaccination process but the online registration has been ongoing for more than a month already.


Cardinal Santos Medical Center was chosen as one of the pilot sites for the vaccination of children due to its modern facilities and very capable doctors.

“Sinimulan po ang registration para sa ating mga kabataan mula 12-17 noong nakaraang buwan pa at sa ngayon ay meron ng mahigit sa 5,000 registrants, ito ay isang indikasyon na karamihan po ng ating mamamayan ay tiwala sa vaccination program ng ating lokal na pamahalaan (We have started the registration of minors aged 12-17 since last month wherein we now have more than 5,000 registrants. This is an indication that most of our citizens trust the vaccination program of the local government),” Zamora said.

The DOH had earlier said that children with comorbidities, as part of the A3 priority group, will be prioritized in the government’s pilot implementation of the vaccination among minors.

Among the DOH’s list of 11 comorbidities of children are medical complexity, genetic conditions, neurologic conditions, metabolic/endocrine, cardiovascular disease, obesity, HIV infection, tuberculosis, chronic respiratory disease, renal disorders, and hepatobiliary.